IES Diagnostics is a company specialising in clinical biochemistry, born out of the need to advance in the area of diagnosis. Its aim is to improve the diagnosis of diseases with a major impact on society, such as COVID-19. To this end, it makes the latest biomedical discoveries accessible to the public using the most innovative technology and offering a personalised, user-centred service. IES Diagnostics is an expert in the implementation of microsampling technology, allowing highly complex analyses to be carried out from a few drops of sample and by self-collection at home.
Thanks to state-of-the-art equipment, such as the Agility automation system and innovative micro-sample collection devices, IES Diagnostics is able to offer accuracy far superior to manual operation, adapting to all patient and user needs. Currently, IES Diagnostics is specialised in the analysis of the immune capacity against the infectious disease caused by SARS-CoV-2. The complete clinical report of immune status and other medical conditions is the hallmark of IES Diagnostics: a unique, understandable, personalised report based on the latest scientific and medical advances.